Bifonazole

Bifonazole structural formula

CAS Number60628-96-8
Molecular FormulaC22H18N2
Molecular Weight310.400
InChI KeyOCAPBUJLXMYKEJ-UHFFFAOYSA-N
LogP4.77
Synonyms
  • Bifonazole
  • 1-[([1,1'-Biphenyl]-4-yl)(phenyl)methyl]-1H-imidazole
  • 1H-Imidazole, 1-([1,1'-biphenyl]-4-ylphenylmethyl)-
  • 60628-96-8
  • 5-23-04-00292
  • 1H-Imidazole, 1-([1,1'-biphenyl]-4-ylphenylmethyl)-
  • (.+-.)-Bifonazole
  • A-One-L
  • Azolmen
  • Bedriol
  • Bicutrin
  • Bifazol
  • Bifonazol
  • bifosin
  • Mycospor
  • Mycosporan
  • Trifonazole
  • 1-(alpha-(4-Biphenylyl)benzyl)imidazole
  • 1-((4-Biphenylyl)phenylmethyl)-1H-imidazole
  • BRN 0618427
  • EINECS 262-336-6
  • 1H-Imidazole, 1-((1,1'-biphenyl)-4-ylphenylmethyl)-
  • Bifonazolum
  • UNII-QYJ305Z91O

Applications:

HPLC Chiral Separation of Bifonazole on Cyralis CM Column

June 17, 2026

HPLC Method for Analysis of Bifonazole on Cyralis CM Column by SIELC Technologies

High Performance Liquid Chromatography (HPLC) Method for Analysis of Bifonazole.

Bifonazole is an antifungal drug with the chemical formula C22H18N2. It is primarily sold as an ointment that works through inhibiting fungal ergostrol biosynthesis, which enables it to work against dermatophytes.

This application describes a normal-phase chiral HPLC method for the separation of Bifonazole enantiomers using SIELC’s Cyralis CM chiral column. Cyralis CM is a cellulose-based chiral stationary phase (CSP) designed for enantiomeric separations, optical purity testing, chiral impurity analysis, and stereoisomer characterization in pharmaceutical, chemical, agrochemical, and fine chemical applications.

Bifonazole can be retained and analyzed using the Cyralis CM stationary phase column. The analysis utilizes an isocratic method with a mobile phase consisting of Hexane, Ethanol, and DEA. Detection is performed using UV.

Condition

ColumnCyralis CM, 4.6 x 100 mm, 5 µm, 100 A, dual ended
Mobile PhaseHexane/Ethanol/DEA- 85/15/0.5%
Flow Rate1.0 mL/min
DetectionUV 280 nm
Resolution2.32

Description

Class of CompoundsFungicide
Analyzing CompoundsBifonazole

Application Column

Cyralis CM

Column Diameter: 4.6 mm
Column Length: 100 mm
Particle Size: 5 µm
Pore Size: 100 A
Column options: dual ended

Add to cart
Application Analytes:
Bifonazole

Application Detection:
UV Detection
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.

HPLC Analysis of Bifonazole

August 6, 2015

 

Bifonazole is an imidazole antifungal drug with fungicidal properties active against dermatophytes. Legacy L1 was used to retain Bifonazole by reverse phase mechanism.Legacy L1 uses embedded C18 groups on porous silica and is useful for many USP HPLC applications. comparisons to Phenomenex columns are available by request.

Condition

Column Legacy L1, 4.6×250 mm, 5 µm, 100A
Mobile Phase MeOH – 80%
Buffer TFA – 0.1%
Flow Rate 1.0 ml/min
Detection UV, 250 nm

Description

Class of Compounds
 Drug,  Hydrophobic, Ionizable
Analyzing Compounds Paracetamol

 

Application Column

SIELC Legacy L1 HPLC column

Legacy L1

SIELC's family of Legacy columns is based on the United States Pharmacopeia's (USP) published chromatographic methods and procedures. Numerous brands have columns used in USP reference standards and methods. USP has created various designations to group together columns with similar types of packing and properties in the solid phase. SIELC's Legacy columns adhere to these strict requirements and properties, allowing you to easily replace older columns that are no longer available without needing to significantly modify your method or SOPs.

Select options
Application Analytes:
Bifonazole

Application Detection:
UV Detection
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.